首页>
外国专利>
DETERMINATION OF THE RISK OF DISTANT METASTASES IN SURGICALLY TREATED PATIENTS WITH NON-SMALL CELL LUNG CANCER IN STAGE I-IIIA
DETERMINATION OF THE RISK OF DISTANT METASTASES IN SURGICALLY TREATED PATIENTS WITH NON-SMALL CELL LUNG CANCER IN STAGE I-IIIA
展开▼
机译:I-IIIA期非小细胞肺癌手术治疗患者远处转移的风险测定
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a method of determination of the risk of distant metastases in surgically treated patients with non-small cell lung cancer in stage I-IIIA wherein microRNA is extracted from a sample of primary tumor tissue, retrotranscribed into complementary DNA by reverse transcription, quantity of microRNA hsa-miR-660 is examined with the use of quantitative PCR method and the expression value of this microRNA is referred to the corresponding microRNA reference expression values in a disease recurrence prediction model in which low expression value of microRNA hsa-miR-660 is correlated to the high risk of distant metastases.
展开▼